USL255 extended-release topiramate: Dose-proportional pharmacokinetics and tolerability in healthy volunteers

OBJECTIVE: Evaluate the pharmacokinetics (PK), safety, and tolerability of single doses of once-daily USL255, Qudexy XR (topiramate) extended-release capsules, over a wide dosing range. METHODS: Two single-dose, phase I studies in healthy adults were used to evaluate the PK profile and maximum toler...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Annie M, Halvorsen, Mark B, Braun, Tricia L, Johnson, Krista M, Cloyd, James C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Full-Length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283972/
https://www.ncbi.nlm.nih.gov/pubmed/24861853
http://dx.doi.org/10.1111/epi.12654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283972/
https://www.ncbi.nlm.nih.gov/pubmed/24861853
http://dx.doi.org/10.1111/epi.12654

Ejemplares similares